REPLAY | State of Play | Congress' Ambitious Drug Price AgendaHealthcare & Health Policy Subscribers: CLICK HERE for video & audio replays. (For unccoperative browers, cut and past: https://app.hedgeye.com/feed_items/76718) |
On July 30, Macro Policy analyst, J.T. Taylor and I recapped the state of play for Congressional efforts to reform drug price policy in the US.
In this brief call, we went through:
Introduction:17 -2:47
Major Themes: 2:47 - 6:27
Drug Prices: 6.27 - 10:41
White House Position 10:41-12:24
CBO Scores: 12:24 - 13:15
Changes to Part D Benefit Design 13:16 - 16:15
Impact of Changes to Part D Benefit Design: 16:16-18:10
Part D Price Increase History: 18:12 - 19:07
Part B Drug Increases: 19:07-19:52
Lobbyist Positions: 19:53-22:35
What to Watch: 22:35-26:26
Comments from JT Taylor: 26:26-30:51
Q & A: 30:52-26:21